Secondaries announced 5.25.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Aldeyra Therapeutics Inc.
Symbol: ALDX
Price: Last trade $5.60
Description: Re-offer $5.00
Trade Date: 5/26
Shares: 1.8 million
Underwriter(s) Stifel
Rating=Subscription Needed

Company: OvaScience, Inc.
Symbol: OVAS
Price: Last trade $9.78
Description: Re-offer reported to be at or around $7.00
Trade Date: 5/26
Shares: 4 million
Underwriter(s) Leerink Partners
Co Manager(s) H.C. Wainwright
Rating=Subscription Needed